Skip to content
Abierto
Menu

Combined synopsis and solicitation

Biomarkers for FGS

75D30124Q78215

Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

Somalogic Operating Co., Inc.

$38,000.00 obligated so far on USAspending

Description

As published on SAM.gov.

This is a combined synopsis / solicitation for commercial items. This announcement constitutes the only solicitation; quotes are being requested in response. The solicitation number for this requirement is Request for Quote (RFQ) 75D30124Q78215. The Centers for Disease Control and Prevention intends to award a firm-fixed-price purchase order for the commercial items listed in this solicitation. Please see full solicitation and associated clauses / provisions in the attached document for further details.

Questions Due: via email to xvc1@cdc.gov by 12:00 p.m. EDT on Friday 08/16/2024.

Responses Due: via email to xvc1@cdc.gov by 5:00 p.m. EDT on Wednesday, 08/21/2024.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Somalogic Operating Co., Inc.
UEI
CTK7E4CB43M7
CAGE
3Q4R1
Vendor location
Boulder, CO
Contract
75D30124P20172, purchase order
Obligated
$38,000.00
Actions
3 between September 18, 2024 and April 24, 2025
Competition
Competed Under SAP, 1 offer received
Set-aside reported
Small Business Set Aside - Total
Described as
Biomarkers Somascan Assay
Match
solicitation number 75D30124Q78215 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 13, 2024

    Combined synopsis and solicitation

    Due August 21, 2024 at 5:00 PM EDT. SAM.gov, notice 97049607a5ab4aeca7f9eb10d4033d26

Points of contact

Also open from this buyer